Clinical trials
Hyperlipoproteinemia Type II trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 5 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 9 |
| Unknown status | 8 |
| Enrolling by invitation | 3 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Laval University | 3 |
| University of Pennsylvania | 3 |
| Geisinger Clinic | 2 |
| Hospital do Coracao | 2 |
| Medical University of Vienna | 2 |
| Odense University Hospital | 2 |
| Abu Dhabi Health Services Company | 1 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Atlantic Health System | 1 |
| Boston Children's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 46 |
| Hypercholesterolemia | 9 |
| Cardiovascular Diseases | 4 |
| Atherosclerosis | 3 |
| Hyperlipoproteinemia Type III | 3 |
| Diabetes Mellitus | 2 |
| Homozygous Familial Hypercholesterolemia | 2 |
| Hypertension | 2 |
| Hypoalphalipoproteinemias | 2 |
| Obesity | 2 |
Trials
Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.